Idexx laboratories announces first quarter results

Westbrook, maine, may 4, 2021 /prnewswire/ -- achieves reported revenue growth of 24% and organic growth of 21%, driven by cag diagnostics recurring revenue growth of 27% as reported and 23% organic delivers eps of $2.35, representing 82% growth as reported and 73% on a comparable basis increases 2021 revenue guidance to $3,105 million - $3,160 million, reflecting higher expectations for reported growth of 14.5% - 16.5% and organic growth of 13% - 15%, supported by projected cag diagnostics recurring revenue growth of 16% - 17.5% as reported and 14.5% - 16% organic raises 2021 eps outlook to $7.88 - $8.18, reflecting expectations for 1.5% higher organic revenue growth and targeted operating margin improvement of 270 - 320 basis points as reported and 150 - 200 basis points on a comparable basis idexx laboratories, inc. (nasdaq: idxx), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced first quarter results, as well as an update on u.s. companion animal diagnostics market trends. first quarter results the company reports revenues of $778 million for the first quarter of 2021, an increase of 24% as reported and 21% organic.
IDXX Ratings Summary
IDXX Quant Ranking